Inflammation-Targeting Mesenchymal Stem Cells Combined with Photothermal Treatment Attenuate Severe Joint Inflammation

© 2023 Wiley-VCH GmbH.

Bibliographische Detailangaben
Veröffentlicht in:Advanced materials (Deerfield Beach, Fla.). - 1998. - 36(2024), 11 vom: 01. März, Seite e2304333
1. Verfasser: Shin, Min Jun (VerfasserIn)
Weitere Verfasser: Park, Jun-Young, Park, Jun Young, Lim, Su Hyun, Lim, Hyoungsub, Choi, Jin Kyeong, Park, Chul-Kyu, Kang, Youn Joo, Khang, Dongwoo
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2024
Zugriff auf das übergeordnete Werk:Advanced materials (Deerfield Beach, Fla.)
Schlagworte:Journal Article arthritis inflammation-educated mesenchymal stem cells membrane conjugations mesenchymal stem cells migration abilities photothermal therapies Triamcinolone 1ZK20VI6TY Anti-Inflammatory Agents mehr... Gold 7440-57-5
LEADER 01000caa a22002652 4500
001 NLM36587079X
003 DE-627
005 20240315232945.0
007 cr uuu---uuuuu
008 231226s2024 xx |||||o 00| ||eng c
024 7 |a 10.1002/adma.202304333  |2 doi 
028 5 2 |a pubmed24n1330.xml 
035 |a (DE-627)NLM36587079X 
035 |a (NLM)38096399 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Shin, Min Jun  |e verfasserin  |4 aut 
245 1 0 |a Inflammation-Targeting Mesenchymal Stem Cells Combined with Photothermal Treatment Attenuate Severe Joint Inflammation 
264 1 |c 2024 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 15.03.2024 
500 |a Date Revised 15.03.2024 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a © 2023 Wiley-VCH GmbH. 
520 |a Current clinical therapeutic efficacy for the treatment of osteo- and rheumatoid-arthritis is obviously limited. Although mesenchymal stem cells (MSCs) are considered as a source of promising regenerative therapy, un-modified or genetically engineered MSCs injected in vivo restrict their clinical utility because of the low drug efficacy and unpredicted side effect, respectively. Herein, a strategy to enhance the migration efficacy of MSCs to inflamed joints via an inflammation-mediated education process is demonstrated. To reinforce the limited anti-inflammatory activity of MSCs, gold nanostar loaded with triamcinolone is conjugated to MSC. Furthermore, near-infrared laser-assisted photothermal therapy (PTT) induced by gold nanostar significantly elevates the anti-inflammatory efficacy of the developed drugs, even in advanced stage arthritis model. An immunological regulation mechanism study of PTT is first suggested in this study; the expression of the interleukin 22 receptor, implicated in the pathogenesis of arthritis, is downregulated in T lymphocytes by PTT, and Th17 differentiation from naïve CD4 T cell is inhibited. Collectively, inflammation-targeting MSCs conjugated with triamcinolone-loaded gold nanostar (Edu-MSCs-AuS-TA) promote the repolarization of macrophages and decrease neutrophil recruitment in joints. In addition, Edu-MSCs-AuS-TA significantly alleviate arthritis-associated pain, improve general locomotor activity, and more importantly, induce cartilage regeneration even for severe stages of arthritis model 
650 4 |a Journal Article 
650 4 |a arthritis 
650 4 |a inflammation-educated mesenchymal stem cells 
650 4 |a membrane conjugations 
650 4 |a mesenchymal stem cells 
650 4 |a migration abilities 
650 4 |a photothermal therapies 
650 7 |a Triamcinolone  |2 NLM 
650 7 |a 1ZK20VI6TY  |2 NLM 
650 7 |a Anti-Inflammatory Agents  |2 NLM 
650 7 |a Gold  |2 NLM 
650 7 |a 7440-57-5  |2 NLM 
700 1 |a Park, Jun-Young  |e verfasserin  |4 aut 
700 1 |a Park, Jun Young  |e verfasserin  |4 aut 
700 1 |a Lim, Su Hyun  |e verfasserin  |4 aut 
700 1 |a Lim, Hyoungsub  |e verfasserin  |4 aut 
700 1 |a Choi, Jin Kyeong  |e verfasserin  |4 aut 
700 1 |a Park, Chul-Kyu  |e verfasserin  |4 aut 
700 1 |a Kang, Youn Joo  |e verfasserin  |4 aut 
700 1 |a Khang, Dongwoo  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Advanced materials (Deerfield Beach, Fla.)  |d 1998  |g 36(2024), 11 vom: 01. März, Seite e2304333  |w (DE-627)NLM098206397  |x 1521-4095  |7 nnns 
773 1 8 |g volume:36  |g year:2024  |g number:11  |g day:01  |g month:03  |g pages:e2304333 
856 4 0 |u http://dx.doi.org/10.1002/adma.202304333  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 36  |j 2024  |e 11  |b 01  |c 03  |h e2304333